Harbour Investments’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$49.6M Buy
228,025
+55,990
+33% +$12.4M 0.77% 23
2025
Q4
$39.3M Buy
172,035
+146,611
+577% +$33.4M 0.8% 19
2025
Q3
$5.89M Buy
25,424
+616
+2% +$125K 0.13% 133
2025
Q2
$4.6M Buy
24,808
+44
+0.2% +$8.18K 0.12% 160
2025
Q1
$5.19M Buy
24,764
+1,806
+8% +$351K 0.15% 121
2024
Q4
$4.08M Buy
22,958
+780
+4% +$143K 0.12% 152
2024
Q3
$4.38M Sell
22,178
-943
-4% -$176K 0.13% 133
2024
Q2
$3.97M Buy
23,121
+808
+4% +$134K 0.13% 134
2024
Q1
$4.06M Buy
22,313
+902
+4% +$155K 0.14% 133
2023
Q4
$3.32M Buy
21,411
+2,842
+15% +$414K 0.14% 137
2023
Q3
$2.77M Buy
18,569
+3,888
+26% +$571K 0.14% 147
2023
Q2
$1.98M Buy
14,681
+34
+0.2% +$4.99K 0.1% 206
2023
Q1
$2.33M Buy
14,647
+192
+1% +$29.4K 0.13% 150
2022
Q4
$2.34M Sell
14,455
-9,276
-39% -$1.42M 0.14% 135
2022
Q3
$3.63M Hold
23,731
0.25% 69
2022
Q2
$3.63M Buy
+23,731
New +$3.63M 0.25% 69
2021
Q4
$3.04M Sell
22,478
-53,653
-70% -$6.34M 0.18% 113
2021
Q3
$8.21M Sell
76,131
-3,903
-5% -$446K 0.26% 68
2021
Q2
$9.02M Buy
80,034
+4,043
+5% +$455K 0.29% 64
2021
Q1
$8.22M Buy
+75,991
New +$8.13M 0.3% 64

Other funds holding ABBV

Harbour Investments's ABBV Position: Q1 2026 in Review

Harbour Investments increased its AbbVie (ABBV) stake by 33% in Q1 2026, buying an estimated $12.4M and bringing the position to 228,025 shares worth $49.6M. The position accounts for 0.77% of the portfolio, ranked #23.

Harbour Investments first reported a position in ABBV in Q1 2021 and has held it in 20 quarters since. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Harbour Investments held 228,025 shares of AbbVie worth $49.6M as of Q1 2026.
  • Harbour Investments bought 55,990 AbbVie shares in Q1 2026, an estimated $12.4M.
  • AbbVie made up 0.77% of Harbour Investments's portfolio in Q1 2026, its #23 holding.
  • Harbour Investments first reported a position in AbbVie in Q1 2021 and has held it in 20 quarters since.
  • 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Harbour Investments's 13F filing for Q1 2026, filed 15 May 2026.